QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel

NCT02559674 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

BIOLOGICAL: Gemcitabine
BIOLOGICAL: Nab-paclitaxel
BIOLOGICAL: ALT-803

Sponsor

Altor BioScience